Stay updated on Pembrolizumab in Endometrial Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Endometrial Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Endometrial Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedPage revision updated from v3.3.1 to v3.3.2 with no visible changes to study content or layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoChange DetectedA note clarifying that publications are automatically filled from PubMed was added, and the page revision tag was updated to v3.3.1. The previous PubMed-related note and the older revision tag (v3.2.0) were removed.SummaryDifference0.1%

- Check26 days agoChange DetectedThe government funding and operating status banner at the top of the page has been removed. The rest of the study details and content remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check41 days agoChange DetectedNo significant changes to core study content are visible between the two screenshots; the page still shows the same study details and structure. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check69 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference3%

- Check77 days agoChange DetectedUpdate: version bumped from v3.0.2 to v3.1.0; signifies a new release with updated core content.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Endometrial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Endometrial Cancer Clinical Trial page.